Catalent | CTLT - Ebitda



Ebitda Veränderung Datum
Agilent USD 456M 84M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Bruker USD 110M 101.6M 2026-03
Centene USD 2.56B 3.47B 2026-03
Charles River Laboratories USD 229.8M 28.26M 2026-03
Cigna USD 2.86B 56M 2025-03
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 129M 6M 2026-03
Elevance Health USD 4.21B 2.02B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Humana USD 2.06B 2.35B 2026-03
Illumina USD 469M 137M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
J&J USD 7.19B 2.32B 2025-12
Laboratory Of America USD 605.6M 17.5M 2026-03
Lonza CHF 1.01B 54M 2025-12
McKesson USD 1.88B 206M 2025-12
Merck EUR 1.53B 87M 2026-03
Merck USD 6.3B 2.09B 2025-12
Mettler Toledo International USD 278.99M 100.24M 2026-03
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Quest Diagnostics USD 557M 20M 2026-03
Repligen USD 40.01M 469K 2026-03
Revvity USD 272.91M 24M 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
UnitedHealth USD 9.99B 8.5B 2026-03
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
West Pharmaceutical Services USD 226.2M 7.7M 2026-03